BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15437322)

  • 1. Potentiation of the antimalarial activity of sulfadiazine by 2,4-diamino-5-aryloxypyrimidines.
    GREENBERG J; RICHESON EM
    J Pharmacol Exp Ther; 1950 Aug; 99(4:1):444-9. PubMed ID: 15437322
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphadiazine-resistance in Plasmodium gallinaceum and its relation to other antimalarial compounds.
    BISHOP A; McCONNACHIE EW
    Parasitology; 1950 Jan; 40(1-2):163-74. PubMed ID: 15401181
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation of pyrimethamine by sulphadiazine in human malaria.
    HURLY MG
    Trans R Soc Trop Med Hyg; 1959 Sep; 53():412-3. PubMed ID: 14405526
    [No Abstract]   [Full Text] [Related]  

  • 4. The antimalarial activity of 2,4-diamino-6,7-diphenyl pterin; its potentiation by sulfadiazine and inhibition by pteroylglutamic acid.
    GREENBERG J
    J Pharmacol Exp Ther; 1949 Dec; 97(4):484-7. PubMed ID: 15400135
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic effect of sulphadiazine and dihydrotriazines against blood-induced P. cynomolgy infection.
    NAIR CP; RAY AP; SINGH J
    Indian J Malariol; 1956 Jun; 10(2):131-5. PubMed ID: 13366405
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on Nuri Strain of P. knowlesi. IX. Susceptibility to sulphonamide substituted dihydrotriazine, sulphadiazine and mepacrine.
    RAY AP; NAIR CP
    Indian J Malariol; 1955 Sep; 9(3):197-202. PubMed ID: 13285915
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the antimalarial property of 4-methoxy-6-sulfanilamido-pyrimidine monohydrate (sulfamonomethoxine: DJ-1550) and on its effect on the chloroquine-resistant malaria.
    Yoshinaga T; Tsutsumi Y; Tsunoda K; Yamamura Y
    Arzneimittelforschung; 1970 Sep; 20(9):1206-10. PubMed ID: 4922319
    [No Abstract]   [Full Text] [Related]  

  • 8. SERUM CONCENTRATION AND ANTIBACTERIAL ACTIVITY OF 4-SULFANILAMIDO-5,6DIMETHOXYPYRIMIDINE.
    MADSEN ST
    Am J Med Sci; 1964 Feb; 247():217-22. PubMed ID: 14124711
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxoplasmic uveitis; treatment with pyrimethamine and sulfadiazine.
    BEUERMAN VA; BURNHAM CJ
    Am J Ophthalmol; 1956 Aug; 42(2):217-27. PubMed ID: 13354693
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of metabolites on the antitoxoplasmic action of pyrimethamine and sulfadiazine.
    EYLES DE; COLEMAN N
    Am J Trop Med Hyg; 1960 May; 9():277-83. PubMed ID: 13821130
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies in human malaria; the suppressive action of sulfadiazine and sulfapyrazine against sporozoite-induced vivax malaria (St. Elizabeth strain).
    COATNEY GR; COOPER WC
    Am J Hyg; 1947 Jul; 46(1):105-18. PubMed ID: 20252852
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimalarials: screening of (orally administered) silver solfonamides against Plasmodium berghei.
    Wysor MS
    Chemotherapy; 1975; 21(5):284-8. PubMed ID: 1098869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Further development of the Roehl test for testing antimalarial agents on Plasmodium cathemerium in the canary by intravenous administration].
    Fink E; Dann O
    Z Tropenmed Parasitol; 1967 Dec; 18(4):466-74. PubMed ID: 5613461
    [No Abstract]   [Full Text] [Related]  

  • 14. The antimalarial activity of metachloridine (2-meta-anilamido-5-chloropyrimidine) and other metanilamide derivatives in test infections with P1 asmodium gallinaceum.
    BRACKETT S; WALETZKY E
    J Parasitol; 1946 Aug; 32():325-39. PubMed ID: 20996729
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on antimalarials. I. Synthesis and antimalarial activities of some derivatives of 2,4-diamino-5-substituted amino pyrimidines and 2,4-diamino-6-methyl-5-substituted amino pyrimidines (author's transl)].
    Zhang XP; Zhang XJ; Zheng XH; Chen L; Dai ZR
    Yao Xue Xue Bao; 1980 Dec; 15(12):711-8. PubMed ID: 7257796
    [No Abstract]   [Full Text] [Related]  

  • 16. The antimalarial properties of 2, 4-diamino-5-p-chlorophenyl-6-ethylpyrimidine, daraprim.
    SCHMIDT LH; GENTHER CS
    J Pharmacol Exp Ther; 1953 Jan; 107(1):61-91. PubMed ID: 13035646
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthetic antimalarials; the preparation of certain derivatives of sulfanilamide.
    DRAKE NL; EAKER CM
    J Am Chem Soc; 1946 Aug; 68():1602-6. PubMed ID: 20994995
    [No Abstract]   [Full Text] [Related]  

  • 18. Sulfadiazine and sulfamerazine in combined sulfonamide therapy.
    KANTOR TG
    N Y State J Med; 1950 May; 50(10):1237-40. PubMed ID: 15416947
    [No Abstract]   [Full Text] [Related]  

  • 19. Study of stability of sulfadiazine sodium injection. III. An investigation of degradation products of sulfadiazine sodium.
    SWARTZ CJ; AUTIAN J
    J Am Pharm Assoc Am Pharm Assoc; 1958 Jul; 47(7):490-3. PubMed ID: 13563251
    [No Abstract]   [Full Text] [Related]  

  • 20. NEW and nonofficial remedies: sulfadiazine, sulfamerazine and sulfamethazine mixtures.
    J Am Med Assoc; 1950 Jul; 143(12):1069. PubMed ID: 15421898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.